GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » Cyclically Adjusted PB Ratio

Shanghai Haohai Biological Technology Co (SHSE:688366) Cyclically Adjusted PB Ratio : 0.94 (As of Jun. 04, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Shanghai Haohai Biological Technology Co's current share price is ¥53.11. Shanghai Haohai Biological Technology Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 was ¥56.61. Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio for today is 0.94.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SHSE:688366' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.94   Med: 1.08   Max: 1.29
Current: 1.08

During the past 11 years, Shanghai Haohai Biological Technology Co's highest Cyclically Adjusted PB Ratio was 1.29. The lowest was 0.94. And the median was 1.08.

SHSE:688366's Cyclically Adjusted PB Ratio is ranked better than
57.86% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs SHSE:688366: 1.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Haohai Biological Technology Co's adjusted book value per share data of for the fiscal year that ended in Dec24 was ¥24.189. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥56.61 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.27 1.07

Shanghai Haohai Biological Technology Co Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 - - - 1.07

Competitive Comparison of Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio falls into.


;
;

Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=53.11/56.61
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Shanghai Haohai Biological Technology Co's adjusted Book Value per Share data for the fiscal year that ended in Dec24 was:

Adj_Book=Book Value per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=24.189/114.8925*114.8925
=24.189

Current CPI (Dec24) = 114.8925.

Shanghai Haohai Biological Technology Co Annual Data

Book Value per Share CPI Adj_Book
201512 15.119 100.600 17.267
201612 16.494 102.600 18.470
201712 18.179 104.500 19.987
201812 20.513 106.500 22.129
201912 21.908 111.200 22.635
202012 22.053 111.500 22.724
202112 23.211 113.108 23.577
202212 22.621 115.116 22.577
202312 23.535 114.781 23.558
202412 24.189 114.893 24.189

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Haohai Biological Technology Co  (SHSE:688366) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Tang Min Jie Directors, senior managers
Du Peng Core technical personnel
Hou Yong Tai Director, core technical staff
Jiang Li Xia Core technical personnel
Core technical personnel
Liu Lu Core technical personnel
Ren Cai Xia senior management
Wang Wen Bin Senior management, core technical personnel
Wu Jian Ying Directors, senior managers
Liu Yuan Zhong Supervisors
Huang Ming Director
Zhang Jun Dong Senior management, core technical personnel
You Jie Director
Tian Min senior management
Chen Yi Yi Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines